A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts

Journal of the Pancreas

Volumn 10, Issue 2, 2009, Pages 163-168

  Sreenarasimhaiah, Jayaprakash ^a   Lara, Luis F ^a   Jazrawi, Saad F ^a   Barnett, Carlton C ^a   Tang, Shou Jiang ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Carcinoembryonic antigen; Cystadenocarcinoma, mucinous; Cystadenoma, mucinous; Endosonography; Genes, ras; Pancreatic cyst; Pancreatic neoplasms

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GENOMIC DNA; K RAS 2 PROTEIN; K RAS PROTEIN; UNCLASSIFIED DRUG; MUCIN;

ADULT; ALLELIC IMBALANCE; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MUCINOUS CYSTIC NEOPLASM; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PANCREAS CYST; POINT MUTATION; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; CYST; GENETICS; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; ONCOGENE RAS; PANCREAS; PANCREAS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY;

BIOPSY, FINE-NEEDLE; CARCINOEMBRYONIC ANTIGEN; CYST FLUID; CYSTS; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; ENDOSONOGRAPHY; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUCINS; PANCREAS; PANCREATIC CYST; PANCREATIC NEOPLASMS; POINT MUTATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 66149131848     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Rafique A, Freeman S, Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clin Radiol 2007; 62:1142-53.
2. Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004; 99:844-50.
3. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126:1330-6.
4. Linder JD, Geenen JE, Catalano MF. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest Endosc 2006; 64:697-702.
5. Shami VM, Sundaram V, Stelow EB, Conaway M, Moskaluk CA, White GE, et al. The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia. Pancreas 2007; 34:466-9.
6. Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade. Cancer 2006; 108:163-73.
7. Salla C, Chatzipantelis P, Konstantinou P, Karoumpalis I, Sakellariou S, Pantazopoulou A, Manika Z. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP. J Pancreas (Online) 2007; 8:715-24.
8. Laucirica R, Schwartz MR, Ramzy I. Fine needle aspiration of pancreatic cystic epithelial neoplasms. Acta Cytol 1992; 36:881-6.
9. Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2006; 140:448-53.
10. Schoedel KE, Finkelstein SD, Ohori NP. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Diagn Cytopathol 2006; 34:605-8.
11. Ohori NP, Khalid A, Etemad B, Finkelstein SD. Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreas. Diagn Cytopathol 2002; 27:42-6.
12. Khalid A, Nodit L, Zahid M, Bauer K, Brody D, Finkelstein SD, McGrath KM. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006; 101:2493-500.
13. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25:579-86.
14. Nagai K, Doi R, Kida A, Kami K, Kawaguchi Y, Ito T, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 2008; 32:271-8.
15. Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol 2007; 102:2339-49.
16. Lee LY, Hsu HL, Chen HM, Hsueh C. Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. Int J Surg Pathol 2003; 11:235-9.
17. Scheiman JM. Management of cystic lesions of the pancreas. J Gastrointest Surg 2008; 12:405-7.
18. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28:977-87.
19. Kitago M, Ueda M, Aiura K, Suzuki K, Hoshimoto S, Takahashi S, et al. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas. Int J Cancer 2004; 110:177-82.
20. Khalid A, Finkelstein S, Le Blanc J, Kaushik N, Ahmad NA, Brugge WR, et al. Pancreatic cyst fluid DNA analysis detects malignant cysts: final report of the PANDA study. Gastrointest Endosc 2007; 65:AB102.
21. Pugliese V, Pujic N, Saccomanno S, Gatteschi B, Pera C, Aste H, et al. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and k-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001; 54:595-9.
22. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg 2002; 9:76-85.
23. Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Virchows Arch 2002; 441:437-43.
24. Abe T, Fukushima N, Brune K, Boehm C, Sato N, Matsubayashi H, et al. Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms. Clin Cancer Res 2007; 13:6019-25
25. Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, et al. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas. Int J Oncol 2002; 21:1067-72.